Highlights from: The Making of KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/7b/1a/da/7b1ada88-0c33-9ffe-65e3-c4ed5bd1ad9f/mza_7175331752938666127.jpeg/600x600bb.jpg

"Lecture-casts"- A Lecture Series on General Chemistry

Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC

107 episodes

4 days ago

Are you interested in learning about General Chemistry ! Are you passionate about science and want to learn about it in a fun and engaging way! Check out " Lecture-casts"- A Podcast Lecture Series in Chemistry" on Spotify! Don't forget to subscribe! We are grateful to have some of the best science educators and thought leaders! Thanks.

Chemistry

Science

RSS

All content for "Lecture-casts"- A Lecture Series on General Chemistry is the property of Mr. David Joshua Ferguson, MS, PharmD Candidate, RSci MRSB MRSC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Chemistry

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40127158/3391331d5408e644.jpeg

Highlights from: The Making of KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

"Lecture-casts"- A Lecture Series on General Chemistry

36 minutes 56 seconds

2 weeks ago

Highlights from: The Making of KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

---In this episode , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--

Please note: The views of this podcast represent those of my guest(s) and I.

Music citation: Open source